Join Our On-Demand Webinar, with Dr. Brian Bobb & Annie Bell, PA-C on Antibiotic Stewardship in Outpatient Care.

Menu Close
Close
Contact Us

Clinical Operations Journal by Dx Direct

How to use Febridx Test
Dx Direct

How to Use the FebriDx Test and Interpret the Results?

The FebriDx test is a rapid point-of-care test that analyzes a small fingerstick blood sample for two host-response biomarkers: Myxovirus resistance protein A (MxA) and C-reactive protein (CRP). Together, these biomarkers help healthcare professionals differentiate bacterial from non-bacterial causes of acute respiratory infection. The test provides results in approximately 10 minutes, making it useful when a clinician needs additional information during an acute respiratory infection assessment. FebriDx results should always be considered alongside the patient’s symptoms, clinical examination, and other available diagnostic information. How Does the FebriDx Test Work? FebriDx

Read More »
August 28, 2026 No Comments
Diagnostics

Antibiotic stewardship is actually a financial win.

The ROI of Rapid Diagnostics: Can a 10-Minute Test Actually Save You Money? Every unnecessary antibiotic prescription costs more than the price of the medication itself. It can lead to repeat visits, adverse drug reactions, unnecessary laboratory testing, lower patient satisfaction when symptoms persist, and mounting pressure on antibiotic stewardship programs. Add clinician time, overcrowded waiting rooms, and declining reimbursement margins, and the financial impact becomes much larger than most healthcare organizations realize. Urgent care centers and emergency departments face this challenge every day. A patient walks in with fever,

Read More »
August 24, 2026 No Comments
Antibiotic Stewardship

Why Distinguishing Viral vs. Bacterial Infections Remains a Challenge in Urgent Care

Distinguishing between viral and bacterial infections remains one of the most common diagnostic challenges in primary care and urgent care settings. Patients frequently present with similar symptoms regardless of the underlying cause, making accurate diagnosis difficult during a single clinical encounter. This challenge is amplified by time constraints, patient expectations, and the limitations of symptom-based evaluation. Overlapping Clinical Symptoms Viral and bacterial infections often share the same clinical presentation, particularly in respiratory illnesses. Symptoms such as fever, cough, sore throat, fatigue, and body aches are common to both. In early

Read More »
June 4, 2025 2 Comments
Dx Direct

FDA Approved vs. FDA Cleared: Understanding the Key Difference You Need to Know

In recent years, advanced consumer technology has rapidly evolved to include health-monitoring features, from fitness trackers to wearable devices. As these products gain popularity, more and more tech companies are seeking FDA approval or clearance to market their devices. But here’s the catch: FDA approval and FDA clearance aren’t the same thing. Knowing the difference can be crucial to understanding the safety and effectiveness of the devices you’re using. Let’s break it down. What Does the FDA Do? The Food and Drug Administration (FDA) is responsible for ensuring that foods, drugs, and

Read More »
June 4, 2025 No Comments

Simplifying Point-of-Care Adoption

Supporting better decisions without adding complexity.

FebriDx is intended to support clinical decision-making and must be interpreted in the context of signs, symptoms, patient history, and clinical judgment. It does not identify a specific pathogen and is not a standalone diagnostic.

FebriDx® is manufactured by Lumos Diagnostics. Dx Direct serves as an authorized distribution channel and does not manufacture the product.
Get in Touch
Office
2000 PGA Blvd., Ste. 4440, Palm Beach Gardens, FL 33408
Links
Get in Touch
Linkedin Instagram

© 2026. All Rights Reserved.

Webinar